key: cord-0297356-7gj2cl8r authors: Bertram, R.; Bartsch, V.; Sodmann, J.; Hennig, L.; Muejde, E.; Stock, J.; Ruedig, V.; Sodmann, P.; Todt, D.; Steinmann, E.; Hitzl, W.; Steinmann, J. title: Breakthrough Infections with SARS-CoV-2 in Vaccinated Students After a Festive Event - Identification of Risk Factors date: 2021-12-23 journal: nan DOI: 10.1101/2021.12.21.21266895 sha: 63f23397b49c667950ebf0f3365edfd55b13c859 doc_id: 297356 cord_uid: 7gj2cl8r We report an outbreak with SARS-CoV-2 breakthrough infections related to a festive event in Northern Bavaria, Germany in October 2021, with 24 of 95 participants infected. Correlation analyses among 16 interrogated variables revealed that duration at the event and conversation with the supposed index person were significant risk factors. Abstract-word count: 49 34 We report an outbreak with SARS-CoV-2 breakthrough infections related to a festive event March 11, 2020 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). COVID-43 19 outcomes range from asymptomatic to multifactorial with fatality rates of around 1.5-2% in 44 developed countries (https://www.statista.com/statistics/1105914/coronavirus-death-rates-45 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 worldwide/). SARS-CoV-2 is largely transmitted airborne, by aerosols and droplets (1). A viral 46 load up to ~3,000 SARS-CoV-2 particles has been reported in 1 L of exhaled breath of infected 47 individuals (2), with an infectious dose as low as 10 aerosol-borne SARS-CoV-2 particles (3). Airborne transmission is positively correlated to proximity and duration of unprotected contacts 49 to infected individuals (4). Accordingly, non-pharmaceutical prevention interventions include 50 medical-grade face masks, handy hygiene, social distancing and ventilation of indoor spaces (5). Safe and effective vaccines have a game-changer potential against the COVID-19 pandemic. As The study 68 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2021. ; https://doi.org/10. 1101 The event took place in Northern Bavaria, Germany, in October 20, 2021 with a duration of 69 about 8h in a poorly ventilated room of about 85 m 2 and a garage with less traffic. Exactly 100 70 students were sojourning at the location. Access was limited to those vaccinated, recovered or 71 tested negative for SARS-CoV-2 by either PCR or antigen point-of-care test (AgPOCT) before 72 (online Technical Appendix Table 1 ). Participants neither wore face masks nor practiced social 73 distancing during the event. All further descriptions and calculations pertain to 95 persons (95%) 74 who provided data associated with the event. Participants were 53 males (56%) and 42 females (44%). In the aftermath of the event, 24 (25%) 76 were diagnosed positive for SARS-CoV-2 (online Technical Appendix Table 2 ). All of the PCR CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101/2021.12.21.21266895 doi: medRxiv preprint COVID-19. The participants attended the event for 60 to 510 min (mean 268 min, median 285 92 min). At least 89 guests were at the venue simultaneously with the supposed index person. Persons reported contacts with 4 -80 other guests (mean 19.2, median 16). Figure 1 provides an 94 overview of contact among all participants (Figure 1, panel A) , or only between those tested 95 positive after the event (Figure 1, panel B) . Interactive graphs provide contact profiles for each iii) The risk of infection was significantly lower upon heterologous vaccination with AZD+BNT 113 (23%) than with AZD+AZD (60%) (Fisher's Exact, two-sided, p = 0.0489) 114 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2021. ; https://doi.org/10. 1101 In addition, the following non-significant observations were found: reports on waned efficiencies of the currently approved vaccines in the delta surge (11, 12). Furthermore, vaccine effects decrease with time after administration (13). A three-shot 135 vaccination regimen with BNT162b2 as a "booster" increases efficiacy against delta (14, 15) and 136 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101/2021.12.21.21266895 doi: medRxiv preprint accordingly, only 1 of 7 individuals (14%) with three doses of vaccine became infected in our 137 study. Our data provide evidence that duration of stay at an event and conversation to index persons are 139 major risk factors for COVID-19 infection during crowded indoor events with poor ventilation. Since currently available vaccines do not provide sterile immunity, high-quality testing of 141 participants should be considered a mandatory measure to avoid SARS-CoV-2 infections at 142 gatherings, irrespective of the vaccination status. Further studies that include larger cohorts are 143 required to provide insights into the interplay of risk factors for SARS-CoV-2 transmission. Acknowledgments 146 We thank the Paracelsus Medical University for their support. Infection 180 fatality rate of SARS-CoV2 in a super-spreading event in Germany Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant Breakthrough Infections with SARS-CoV-2 Variants Effectiveness of Covid-19 vaccination against risk 189 of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population 190 cohort study. Preprints with The Lancet Effectiveness of 192 a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in 193 Israel: an observational study Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel transmission of SARS-CoV-2. Science. 2020 10 16;370(6514):303-4. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101/2021.12.21.21266895 doi: medRxiv preprint It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 23, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprintThe copyright holder for this this version posted December 23, 2021. ; https://doi.org/10. 1101